Skip to content
HW200901 Operationalize Expanded Access Programs logo FINAL

February 2023

Boston, MA

Your Next EAP Meeting:
Operationalise: Early Access Programmes Europe
October 18-20th, London

  • Home
  • About
    • About Event
  • Program
    • 2022 Speakers
    • Pre-Conference Workshop Day
    • Agenda
      • Conference Day One
      • Conference Day Two
  • Partner
    • Partnership Opportunities
    • 2022 Partners
  • Get Involved
    • Register Interest
    • Contact us

OncoBay Clinical

By csamuel | 5th May 2020

OncoBay Clinical is a niche CRO focused on Immunotherapy with a specialization in cellular therapy trial operations. As a subsidiary of Moffitt Cancer center we leverage the scientific and manufacturing infrastructure expertise and apply that directly to full service commercial CRO operations. OncoBay’s solution is more than just a minor enhancement to the expected conventional CRO process, we’ve pioneered an innovative approach. Built on a cellular therapy focus, streamlined testing framework, highly trained site network and a dedicated team of experienced professionals, OncoBay offers custom-curated services for IO clinical trials. This is IO research, reimagined.

www.oncobay.com

OUR CONTACT DETAILS

T: +1 617 455 4188
E: info@hansonwade.com

Lost?

Event Guide

Register

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

EVENT DETAILS

This meeting will run in Boston in February 2023

SEARCH

ORGANISED BY

HansonWade Logo

Terms & Conditions

Privacy Policy

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.